Hastings Science and Technology Law Journal
Volume 7
Number 2 Summer 2015

Article 3

Summer 2015

The Intersection of Patents and Trade Secrets
Michael R. McGurk
Jia W. Lu

Follow this and additional works at: https://repository.uchastings.edu/
hastings_science_technology_law_journal
Part of the Science and Technology Law Commons
Recommended Citation
Michael R. McGurk and Jia W. Lu, The Intersection of Patents and Trade Secrets, 7 Hastings Sci. & Tech. L.J. 189 (2015).
Available at: https://repository.uchastings.edu/hastings_science_technology_law_journal/vol7/iss2/3

This Article is brought to you for free and open access by the Law Journals at UC Hastings Scholarship Repository. It has been accepted for inclusion in
Hastings Science and Technology Law Journal by an authorized editor of UC Hastings Scholarship Repository. For more information, please contact
wangangela@uchastings.edu.

MCGURK_FINAL EDITS (DO NOT DELETE)

5/1/2015 4:28 PM

The Intersection of Patents and Trade Secrets
by MICHAEL R. MCGURK* AND JIA W. LU**

I. Introduction ............................................................................................ 190
II. Development of Patent Law .................................................................. 192
III. Development of Trade Secret Law ...................................................... 194
IV.Intersection of Patent Law and Trade Secret Law ................................ 196
A. Choosing between Patents and Trade Secrets ......................... 198
1. Patentability ....................................................................... 200
2. Terms of Protection ........................................................... 203
3. Enforcement ....................................................................... 204
4. Injunctions ......................................................................... 205
5. Prior User Rights ............................................................... 206
6. Disclosure .......................................................................... 207
7. Costs…………………………………………………… ... 208
B. Choosing Both Patents and Trade Secrets ............................... 209
1. Pre-publication ................................................................... 210
2. Different Aspects of the Invention..................................... 211
3. Best Mode .......................................................................... 212
V. Conclusion ............................................................................................ 213

*

Michael R. McGurk is a partner in the Boston, MA office of Finnegan, Henderson, Farabow,
Garrett & Dunner LLP. Mr. McGurk has over 25 years of experience in IP matters involving all
aspects of patent law, primarily in pharmaceutical, chemical, medical device, and mechanical
technologies, including robotics. His practice includes due diligence matters; opinion work;
global portfolio development, strategy, and management; as well as adversarial proceedings,
including litigation, interferences and post-grant review procedures.
**
Jia Lu is an attorney in the Washington, DC office of Finnegan, Henderson, Farabow, Garrett
& Dunner LLP. Ms. Lu focuses her practice on patent litigation, prosecution, post-grant
procedures, and client counseling in the fields of electrical and computer technologies,
telecommunications, and business methods. She is also a former patent examiner at the USPTO,
examining U.S. and international patent applications involving pulse and digital communications
[189]

MCGURK_FINAL EDITS (DO NOT DELETE)

190

5/1/2015 4:28 PM

HASTINGS SCIENCE AND TECHNOLOGY LAW JOURNAL

I.

[Vol. 7:2

Introduction

Patents and trade secrets are the only two forms of intellectual property
that protect information—patents protect patentable information (innovation),
while trade secrets can protect patentable information and any other
information providing economic value to the holder. Thus, the same
information can often be protectable by patents or trade secrets. However, the
bodies of laws governing each are far from similar. This paper explores the
different origins, developments, protections, and consequences of patent and
trade secret law to show their differences and numerous similarities. This
paper highlights a number of factors and considerations a company should
evaluate when choosing between patents and/or trade secrets to protect its
information.
Patent law is at the forefront of the intellectual property regime. It is
modeled on the utilitarian framework and creates a limited monopoly that
encourages the production of statutory categories of inventions—namely,
processes, machines, a manufacture or article of manufacture, and
compositions of matter. The patent system benefits the public by spurring
innovation and requiring disclosure of the patented invention in return—the so
called “quid pro quo.” After the patent expires, the disclosed innovation
becomes part of the public domain, remains free for public consumption and
use, and then is no longer susceptible to charges of patent infringement by the
patent holder.1 To obtain a utility patent, an inventor must first file an
application in the United States Patent and Trademark Office (USPTO)
describing the invention. The USPTO conducts an independent review of the
invention as described for compliance with several statutory requirements,
including patent-eligible subject matter, usefulness, novelty, and nonobviousness. The application must also describe the invention in a way that
would enable others to make and use the invention. While the threshold for
usefulness (utility) is low,2 the thresholds for novelty and nonobviousness are
rigorous, and the threshold for patent-eligibility has recently become
extraordinarily high (and somewhat unsettled) for some classes of inventions.3
1. This is not to be confused with the situation where a product, for example that was
covered by a now expired patent, may still be infringing another non-expired patent owned by the
same person or a third party. Likewise, in some instances, a “use” falling within the expired
patent may be subject to later filed but not yet e xpired patents covering that “use.” If that is the
case, such “use” may be subject to a claim of infringement of the later filed patent.
2. The old joke in chemical arts was to throw your compound on the grass, and if the grass
grows, it has utility as a fertilizer, and if it dies, as an herbicide.
3. The Supreme Court in recent years has been very active in further developing the metes
and bounds of what is considered a threshold issue, and what was for thirty plus years a very
sleepy subject. See, e.g., Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347 (2014);
Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107 (2013); Bilski v.
Kappos, 561 U.S. 593, 608-09 (2010); Prometheus Labs., Inc. v. Mayo Collaborative Servs. &
Mayo Clinic Rochester, 628 F.3d 1347 (Fed. Cir. 2010).
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If the patent application passes review, then the USPTO allows the application
to be issued as a patent. The inventor (or company to which the patent is
assigned) then enjoys twenty years from the earliest filing or priority date (the
so-called “20 year term”) of exclusive rights to exclude others from making,
using, or selling the patented invention.4 Patent rights are powerful tools
because they may bar even those who independently developed or discovered
their invention from practicing their own invention.5
Trade secret law, on the other hand, is not so concerned with
utilitarianism. Instead, trade secret law is centered on the belief that certain
confidential business information of economic value should be protected
against theft. Specifically, the purpose of trade secret law is to prevent
misappropriation of a party’s trade secrets by unfair or commercially
unacceptable means. Although trade secret law promotes competition and
innovation through its aim to preserve acceptable business practices, this
indirect effect has at its core the notion that trade secret law focuses only on the
immediate parties involved, and is more akin to tort and contract law than to
patent law.
Unlike patent law, which is grounded in our U.S. Constitution and based
on federal law, there is currently no federal civil cause of action for trade secret
misappropriation. Trade secret law always has been, and continues to be, a
product of state law. In contrast to patent law, trade secret law covers all forms
of information (whether patentable or not). Further, neither application nor
registration is needed for trade secret protection, and there is no state agency in
charge of reviewing or approving trade secrets. Rather, trade secret law as
such covers any information that is secret, valuable, and protected. Trade
secrets have no expiration date, and can last as long as the information is kept
secret. This could be in perpetuity, over a hundred years, as in the case of the
famous Coca-Cola® formula; or a day, in the case of the forgetful scientist
who accidentally left his notebook out in the open for all in public to see.
Moreover, trade secrets do not protect against independent discovery or reverse
engineering by anyone, including your competitors.
Despite these significant differences, patents and trade secrets are
nonetheless closely intertwined and capable of being used in conjunction to fully
protect information. They not only substitute each other in some circumstances,
but can also complement each other. Therefore, understanding the origins of
patents and trade secrets, the protections they offer, and the legal reach and scope
of each enables an inventor or a company to consider and secure the best
possible protection for their information.
4. Frequently, this concept is incorrectly articulated as a right to make, use, and sell the
patented invention. Instead, the right obtained is one of exclusion only, and always subject to
other third party rights that could dominate or cover your patented invention.
5. This issue is both fact and law intensive. It may depend on when the invention was
conceived and reduced to practice, whether the applicable law is pre- or post-AIA, and/or whether
prior user and/or intervening rights may exist.
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Development of Patent Law

Patent law is the oldest of the different forms of intellectual property
law in the United States. The word “patent” comes from the Latin word
patere, which means, “to be open.” It arose in the fourteenth century in
Venice as an open letter of privilege from the sovereign. The patent system
was later introduced to Great Britain in the sixteenth century, when a
minister used patent grants to induce foreign artisans to introduce
continental technologies into England. Thus, what later became the AngloAmerican patent system originated from what today would be considered
strategic international policy, where immigrants with desirable skills and
knowledge were lured by the promise of an exclusive privilege.6
The first U.S. patent statute was passed in 1790,7 and the first patent
was issued shortly thereafter for a process making pot ash from wood
ashes.8 However, the U.S. patent system did not grow into its full stature
until the 1836 revision,9 when a formal patent examination system replaced
the previous patent registration system. Since 1836, the patent system in
the U.S. has grown dramatically in the number of inventions applied for,
the number of patents issued, and the number of patents litigated. 10 As
demand for patents grew, the patent system developed new rules, such as
the requirement for an “inventive leap,” now known as the obviousness
standard, to limit the number of meaningless patents issued.11
Not surprisingly, this rapid ascent of patents issued in the U.S. resulted in
several pendulum swings of public opinion for more or less protection. In the
early twentieth century, for example, many people resented large companies
with large patent portfolios, and believed that they were too powerful. A
number of large companies had patent portfolios that dominated their
respective industries, and allegedly suppressed competition. Courts during this
period were less willing to enforce patents, and more willing to punish
patentees who exceeded the scope of their patent rights. In the 1940s, the
pendulum swung back in favor of stronger patent protection as the nation
pooled all of its resources for the war efforts, and called on inventors to
develop new technology. Due to mandatory cooperation initiatives adopted by
6. See Edward C. Walterscheid, The Early Evolution of the United States Patent Law:
Antecedents, 76 J. PAT. & TRADEMARK. OFF. SOCIETY 697 (1994) (Part I).
7. See Patent Act of 1790, Ch. 7, 1 Stat. 109-112 (April 10, 1790).
8. Henry M. Paynter, The First Patent, INVENTION & TECHNOLOGY (1990), available at
https://www.me.utexas.edu/~longoria/paynter/hmp/The_First_Patent.html.
9. See Patent Act of 1836, Ch. 357, 5 Stat. 117 (July 4, 1836).
10. B. Zorina Khan, Property Rights and Litigation, THE JOURNAL OF ECONOMIC HISTORY, Vol.
55, No. 1(1995) p.63. (“From 1790 to 1860, a total of 795 patent cases were reported or cited in judicial
decisions”); Federal Judicial Workload Statistics During the twelve month period ended December 31,
1985, A-19 (548 patent cases filed in the year 1985); Lex Machina report showing District Court patent
cases during 2014 (5004 patent cases filed in the year 2014).
11. Fast-forward to the 20th and 21st centuries, complaints about the quality of some U.S. patents
remains a thorn in the side of the USPTO. Under the new AIA post grant provisions, there are now
more cost effective and proven methodologies to marginalizing these patents.

MCGURK_FINAL EDITS (DO NOT DELETE)

SUMMER 2015]

5/1/2015 4:28 PM

THE INTERSECTION OF PATENTS AND TRADE SECRETS

193

the federal government during wartime, patentees had neither the time nor the
ability to exclude domestic competitors from using their patented technology.
However, that all changed after the war because patent protection remained
strong and members of Congress continued to favor a strong patent system.
This pro-patent attitude resulted in the codification of the various patent laws
from the previous 80 years into the first meaningful codification of the
twentieth century, embodied in the historic 1952 Patent Act.12
But in subsequent years, too many patents were issued without much
scrutiny and so, in the 1960s, the public opinion again reversed course against
patents, as the apparent standards for obtaining a patent at the USPTO reached
new lows. As a result, issued patents were not upheld in the courts, and the
different circuit courts routinely reached different conclusions for patent
infringement and validity issues on similar sets of facts. This made
predictability a high risk gamble and forum shopping a primary litigation
tactic. Arguably, the value of patents during this period waned.13
In 1982 Congress sought to improve the quality and importance of
patents, and passed the Federal Courts Improvements Act, which created the
Court of Appeals for the Federal Circuit (“CAFC”).14 Under this Act, the
CAFC had exclusive jurisdiction over all patent appeals from district courts,
and certain other appeals from the PTO and other government courts, resulting
in a more unified treatment of patent cases from different regional district
courts. The CAFC worked tirelessly to strengthen and expand the scope of
patent protection. Most recently in 2011, Congress passed the Leahy-Smith
America Invents Act (“AIA”), the single largest patent law reform since the
Patent Act of 1952.15 The AIA introduced significant changes to the United
States patent system, the most significant being the creation of a first-to-file
system rather than what had been a first-to-invent system, and the creation of
new venues for challenging existing patents.16
Despite these many pendulum swings, the original purpose of the patent
law remains the same, which is to “promote the progress of science and useful
arts, by securing for limited times to authors and inventors the exclusive right
to their respective writings and discoveries.”17 Congress achieves this balance,
in part, by giving patent owners the right to exclude others from making, using,
and selling the patented invention for a specified period of time in exchange
for inventors sharing their invention with the public in the form of a patent

12. See Robert P. Merges, One Hundred Years of Solicitude: Intellectual Property Law, 19002000, 88 CAL. L. REV. 2187 (2000).
13. Robert P. Merges et al., INTELLECTUAL PROPERTY IN THE NEW TECHNOLOGICAL AGE, 110
(3d ed. 2003).
14. Id. at 111.
15. See Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011).
16. The most notable being the updated and improved post grant procedures. See infra note 11.
17. U.S. Const. art I. §8.
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application, and ultimately a patent.18 While the U.S. patent statute is,
relatively speaking, straightforward, it does not by itself ensure a patent system
that perfectly balances societal and personal interests. For example, the patent
grant can sometimes offer more quid than quo,19 because patent owners may
sue for infringement not only those who “steal” (or copy) the patented
invention but also those who did not steal the patented invention; for example,
those who independently developed the same invention.20 But the “quo”
should not be underestimated because the patent grant itself is not selfpolicing. It requires the patent owner to find the infringers and then assert his
patent to seek compliance, a feat (in effort, time, and expense) great enough to
prevent some patent owners from pursing patents in the first place.
III.

Development of Trade Secret Law

Although confidential business information has been maintained and
treated as highly confidential and kept under lock and key (an early
predecessor of trade secrets) long before patents ever existed, trade secret law
itself is a more recent phenomenon. At least one scholar believes that the
concept of a legally protectable trade secret can be traced back to the Roman
law, where a slave was prohibited from stealing the trade secret of his master
and giving it to a competitor.21 That concept later manifested itself as a body
of law protecting business owners during the Renaissance, and was
subsequently codified during the industrial revolution by European nations to
deal with the newfound mobility of labor.
In the United States, courts first recognized trade secrets as a cause of
action in 1837, in Vickery v. Welch.22 In Vickery, the seller of a chocolate mill
contracted to sell the mill, along with the secret of making chocolate, but later
refused to tender to the buyer the written promise not to disclose his secret to
anyone else. The seller argued that such a promise would be an unlawful
restraint of trade. The Massachusetts court disagreed with the seller, ruling
that the promise would have “no consequence to the public whether the secret
art be used by the plaintiff or by the defendant.”23
A collective body of common law that developed after 1837 on trade secret
law was summarized in 1939, and categorized in the Restatement (First) of
Torts. In it, the definition of a trade secret was “any formula, pattern, device or
compilation of information which is used in one’s business, and which gives him

18. This quid pro quo system is derived from the English patent system and retains the elements
of its spirit.
19. Literally translated, quid pro quo means “what for what” or “something for something”; it
does not follow, however, that the exchange is of equal value.
20. The so-called “innocent infringers,” lacking any real intent to infringe but nonetheless
culpable under the statutory scheme.
21. See A. Arthur Schiller, Trade Secrets and the Roman Law: The Actio Servi Corrupti, 30
COLUM. L. REV. 837, 838-839 (1930).
22. Vickey v. Welch, 36 Mass. 523, 527 (1837).
23. Id.
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an opportunity to obtain an advantage over competitors who do not know or use
it.”24 All forms of information were covered, such as “a formula for a chemical
compound, a process of manufacturing, treating or preserving materials, a pattern
for a machine or other device, or a list of customers.”25
The 1939 definition of a trade secret was widely accepted by both state and
federal courts, initially providing consistent court decisions on issues involving
trade secrets. Over time, however, the courts’ reasoning and outcomes in cases
with similar facts began to diverge. The resulting confusion in trade secret cases
was further exacerbated by the Second Restatement of Torts published in 1979,
which altogether eliminated reference to trade secrets on the grounds that the law
of trade secrets had developed into an independent body of law that no longer
relied on general principles of tort law. However, and despite this development,
the original Restatement (First) of Torts remained a major influence on trade
secret law because it had been adopted in many court decisions.
Thus, in 1985, in an effort to return some uniformity to the law of trade
secrets across states and in state and federal courts, the National Conference of
Commissioners on Uniform State Laws issued the model Uniform Trade Secrets
Act (“UTSA”). The UTSA is not binding upon the states, but merely is intended
to serve as a guide to those who wish to draft statutes to protect trade secrets.
States that choose to adopt the UTSA may do so in whole or in part, and are free
to make modifications to the adopted provisions. As of 2014, 48 states and the
District of Columbia have adopted some form of the UTSA. However, those
states have each modified the UTSA, and as a result, despite having a common
origin, no two states have identical trade secret laws. Massachusetts and New
York have not adopted the UTSA, and so far protect trade secrets under their
state statutes or the common law.
Under the UTSA, a trade secret is:
information, including a formula, pattern, compilation, program,
device, method, technique, or process, that: (i) derives independent
economic value, actual or potential, from not being generally
known to, and not being readily ascertainable by proper means by,
other persons who can obtain economic value from its disclosure
or use, and (ii) is the subject of efforts that are reasonable under the
circumstances to maintain its secrecy.26
The UTSA definition differs from the definition in the Restatement (First) of
Torts in a few significant ways. First, the USTA does not require that the
information be in use. Thus, it protects information such as failed research and
24. RESTATEMENT OF TORTS, Explanatory Notes § 757 cmt. b at 5 (1939).
25. Id.
26. Uniform Trade Secrets Act with 1985 amendments § 1 (1985), available at
http://www.uniformlaws.org/shared/docs/trade%20secrets/utsa_final_85.pdf.
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knowledge of what not to do, and any information not currently used but which
has potential economic value. Also, unlike the first Restatement, the UTSA
requires the plaintiff to prove that it took reasonable efforts to maintain secrecy.
In 1995, the American Law Institute published the Restatement (Third) of
Unfair Competition, which summarized the common law of trade secret. The
definition of trade secret in the Restatement (Third) of Unfair Competition
follows the UTSA definition of trade secret, defining a trade secret as “any
information that can be used in the operation of a business or other enterprise and
that is sufficiently valuable and secret to afford an actual or potential economic
advantage to others.”27
As a consequence of the above evolution, the trade secret law followed
today has two primary sources: state law, as embodied in the various state
enactments of the UTSA, and common law, currently codified in the
Restatement (Third) of Unfair Competition.
U.S. protection for trade secrets is also compelled by the U.S.’s
membership in the World Trade Organization (WTO) and adherence to the
intellectual property agreement in the Uruguay Round of the General Agreement
on Tariffs and Trade (GATT) Trade-Related Aspects of Intellectual Property
Rights (TRIPS) in 1994. The TRIPS Article 39, paragraph 2, requires member
nations to provide a means for protecting information that is secret,
commercially valuable because it is secret, and subject to reasonable steps to
keep it secret.28
IV.

Intersection of Patent law and Trade Secret Law

The two bodies of law covering patent and trade secret law serve two very
different purposes in society, something that may be apparent from the different
origins of each. Patent law mainly serves to promote the sharing of information,
while the latter mainly serves to protect an individual or a company from theft,
and therefore promotes secrecy. And because the former is intended to benefit
all of society, it is controlled by the federal government and is susceptible to the
government’s ever-changing policies and goals. The latter, on the other hand, is
affected less by these ups and downs and is less susceptible.
Consequently, trade secret law has evolved more slowly because it is not as
susceptible to the drastic pendulum swings that have affected the patent system.
With the single exception of the Economic Espionage Act passed by Congress in
1996, the federal government has essentially stayed away from creating any
trade secret law. But because of the close relationship between trade secrets and
patents, federal patent cases and federal patent laws do have the ability to impact
trade secrets and their use.
For example, the reform implemented under the AIA of 2011 introduced
significant and historical changes to the U.S. patent system, but also mentioned
trade secrets. This one instance is significant for trade secrets even though it was
27. RESTATEMENT (THIRD) OF UNFAIR COMPETITON § 39 (1995).
28. See Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15,
1994, 1869 U.N.T.S. 299, art. 39, available at http://www.wto.org/english/tratop_e/trips_e/t_
agm3d_e.htm.
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only mentioned once in the AIA. Specifically, the AIA requires the Director of
the USPTO to submit a report to Congress with “[a]n analysis of legal and
constitutional issues, if any, that arise from placing trade secret law in patent
law” stemming from “the operation of prior user rights in selected countries in
the industrialized world.”29 Thus, although the AIA did not create a federal
statutory basis for trade secret law to exist within the patent laws, the
Congressional request clearly acknowledges the inevitable interplay between
patents and trade secrets.
Moreover, it is very clear under the AIA that trade secrets and trade secret
laws are anticipated to arise under the prior user defensive provisions of the new
law. As noted, the most prominent change enacted under the AIA was the
switch from a system that grants a patent to the first inventor to a system that
grants a patent to the first inventor to file. Under pre-AIA, a first inventor was
given the chance to obtain a patent on an invention even if a second inventor
filed for the same invention first, if that first inventor could prove that he had
possession of the invention before the second inventor.30 In a post-AIA under
similar facts, the first inventor loses his right to a patent because the second
inventor filed first, even though the first inventor had possession of the invention
before the second inventor.
This reverseoutcome under the AIA arguably affects the use of trade
secrets because the pre-AIA first inventor had the option to keep his
invention a trade secret for up to twelve months before filing a patent
application on the invention.31 Post-AIA, the first inventor would not be
able to use the invention as a trade secret without risking a second inventor
(the late-comer) beating him to the patent office. In other words, in the
post-AIA world, the first inventor would not be able to seek patent
protection if the latecomer files first.32 While this change incentivizes the
inventor to pursue patent protection over trade secrets, other AIA changes,
some of which are discussed in the next section, might just provide the
opposite incentives.
As illustrated briefly above, there is a delicate and sometimes
conflicting balance between patents and trade secrets. Despite this, as
noted at the beginning of this article, patents and trade secrets coexist to
29. See generally, U.S. PATENT & TRADEMARK OFFICE, REPORT TO CONGRESS:
REPORT ON THE PRIOR USER RIGHTS DEFENSE 1-2 (2012).
30. This is an oversimplification of the legal and factual inquiries required to be analyzed, such as
prior conception, reduction to practice, abandonment, concealment, prior public use, and commercial
activity. This type of information is frequently obtained from documents, including lab notebooks,
interviews/depositions with the inventors and other involved parties, and documentary custodians.
31. In this scenario, a trade secret suggests something of economic (i.e., commercial) value,
and under pre-AIA law, such a secret, commercial use triggered a one year bar date under 35
U.S.C § 102(b) from the first use for the inventor to file for patent protection if patent protection
was desired.
32. Post-AIA law provides some prior user rights (defenses) against patented inventions.
See, e.g., 35 U.S.C. 273 (2011).
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protect information. In fact, the co-existence of patent law and trade secret
law was blessed by the Supreme Court in Kewanee Oil Co. v. Bicron
Corp.33 In Kewanee, the Court found that the policies and purposes of the
patent laws and state trade secret laws were essentially compatible and
could coexist in most, if not all, of the areas where they interface. The court
observed that:
[t]rade secret law and patent law have co-existed in this
country for over one hundred years. Each has its particular
role to play, and the operation of one does not take away from
the need for the other. Trade secret law encourages the
development and exploitation of those items of lesser or
different invention than might be accorded protection under
the patent laws, but which items still have an important part to
play in the technological and scientific advancement of the
Nation. Patent law promotes the sharing of knowledge, and
the efficient operation of industry; it permits the individual
inventor to reap the rewards of his labor by contracting with a
company large enough to develop and exploit it.34
A.

Choosing between Patents and Trade Secrets

The Kewanee court examined three categories of subject matter that
an inventor would consider in choosing between patent protection and trade
secret protection: “(1) the trade secret believed by its owner to constitute a
validly patentable invention; (2) the trade secret known to its owner not to
be so patentable; and (3) the trade secret whose valid patentability is
considered dubious.”35 For the category of subject matter “known to its
owner not to be so patentable,” the court held that there is no conflict or
preemption of patent law by state trade secret law because patent law
would never be applicable to those inventions. For the category of subject
matter “whose valid patentability is considered dubious,” the court held
that on balance, “[e]liminating trade secret law for the doubtfully
patentable invention is thus likely to have deleterious effects on society”
and thus presents no conflict with patent law.36 Finally, for the category of
subject matter “believed by its owner to constitute a validly patentable
invention,” the Court held that trade secret law “presents no reasonable risk
of deterrence from [filing a] patent application.”37
While Kewanee remains good law, some of the court’s presumptions
may be less true today. For example, the court appeared to believe that
while an inventor may try to pursue a patent for dubious patentable subject
33.
34.
35.
36.
37.

Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470, 493 (1974).
Id. at 493.
Id. at 484.
Id. at 489.
Id.
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matter, in the case of subject matter believed to be patentable, “[t]he
possibility that an inventor who believes his invention meets the standards
of patentability will sit back, rely on trade secret law, and after one year of
use forfeit any right to patent protection . . . is remote indeed.”38 In fact,
the Court’s holding that trade secret law does not preempt federal patent
law appeared to be premised on this belief:
[i]f a State, through a system of protection, were to cause a
substantial risk that holders of patentable inventions would not
seek patents, but rather would rely on the state protection
[trade secret], we would be compelled to hold that such a
system could not constitutionally continue to exist. In the
case of trade secret law no reasonable risk of deterrence from
[filing a] patent application by those who can reasonably
expect to be granted patents exists.39
Over four decades later, under circumstances suggestively proscribed
by the Supreme Court in Kewanee, trade secret law and patent law continue
to co-exist, each as vigorous as the other. Although patent law continues to
offer advantages over trade secret law, the possibility that a company may
choose to pursue trade secret protection in lieu of patent protection is not
remote or even surprising.40 Each continues to serve a different purpose,
and each offers advantages that the other does not offer.41 In fact, patents
and trade secrets have become more intertwined and codependent than ever
before. Some argue that recent changes in patent law have created more
incentives to use trade secrets over patents.
Not surprisingly, in light of these changes, a company’s analysis and
decision tree whether to pursue trade secrets or to pursue patents have
become more important and nuanced. The choice between patent protection
or trade secret protection is obvious when one form of protection is
unavailable, but most of the time the choice between patents and trade
secrets requires a careful evaluation of a number of factors, concerns,
consequences, and changes in the law.42 Sometimes the “right” choice for
a company in today’s world would surprise the Kewanee Court.

38. Id. at 490.
39. Id. at 489.
40. The assumption here is that both forms of protection are available but only one, trade secrets,
provides the desired benefits to the owner or is the better business option.
41. A good argument can made for certain innovative (patentable) information that it serves at
least one common purpose, namely to protect the innovation, albeit under different legal principles
already described herein.
42. Because the AIA is new, it will take many years to establish a compelling body of case law
that interprets the new provisions to provide clear legal guidance.
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To illustrate some of these points, we consider two hypothetical
companies: Company A is a large pharmaceutical company that makes
drugs, and company B is a startup high-tech company that makes electronic
devices and software applications. While companies A and B may consider
the same factors in choosing between trade secret and patent protection, the
different nature of their products and the market place may take the
different companies down different paths. For this illustration, we discuss
the following factors in turn: 1) patentability, 2) term of protection, 3)
enforcement considerations, 4) injunctions, 5) prior user rights, 6)
disclosure, and 7) costs. While not exhaustive, these seven factors are
likely the most relevant and should almost always be considered in a trade
secret versus patent analysis.
1.

Patentability

A first, and perhaps most important, inquiry is to determine whether
the information under consideration is patentable. If it is not, or unlikely
patentable, a company’s resources are better spent on seeking trade secret
protection. Although most requirements for patentability, such as
usefulness, novelty, and written description can be determined well before
the Patent Office makes its official determination of patentability,
predicting whether an invention is nonobvious is less straightforward.43
And if the information is not capable of, or has a low likelihood of, being
kept a trade secret then a patent may be the only recourse protection.
Moreover, deciding this patentability issue first has the potential of saving
businesses significant wasted costs.
Patent eligibility
Patent-eligible subject matter is information that 1) belongs to one of
the four statutory categories of patent-eligible subject matter—process,
machine, manufacture or article of manufacture, or composition of matter,
and 2) which do not embrace a judicially recognized exception—laws of
nature, physical phenomena, or abstract ideas. Some information is easily
determined as patent ineligible. For example, customer and supplier lists,
business plans, mathematical formulas, and negative know-how (knowing
what not to do) are generally not patent eligible. Other information, such
as what constitutes a law of nature or an abstract idea, is less clear on
patent eligibility.
43. Cases like KSR and its predecessors have expanded the rationales for a finding of
obviousness by the USPTO and courts, making a pre-filing patent application analysis much more
difficult. As noted supra in note 6, and discussed in the next section, patent eligibility threshold
analyses are complex, and the current jurisprudence from the courts, and guidance from the
USPTO, are in a state of flux between unreasonable and unworkable.
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Recent Supreme Court decisions on patent eligible subject matter
suggest that the scope of patent-eligible subject matter is shrinking. First,
in Bilski v. Kappos, the Supreme Court revised the test for determining
patent eligibility and effectively limited the patent eligibility of business
methods.44 Then, in Mayo Collaborative Services v. Prometheus
Laboratories, Inc.,45 the Court applied the law-of-nature exception and
stated that a method for determining dosing ranges of drugs was patent
ineligible subject matter, and placed into question many pharmaceutical
methods (diagnostics and other technologies) that were once thought to be
patent eligible. In Association for Molecular Pathology v. Myriad Genetics,
Inc.,46 the Court extended the law-of-nature exception to certain isolated
DNA holding those as patent-ineligible. Most recently, in Alice Corp. Pty.
Ltd. v. CLS Bank Int’l,47 the Court held that claims to “generic computer
implementation” of abstract ideas are not eligible for patent protection.
These recent cases cast doubt on the patent eligibility and therefore the
validity of countless granted patents. Many patents have already fallen prey to
these patent-killing seminal cases. For example, because of the Court’s
holding in Alice that generic computer implementations of abstract ideas are
patent-ineligible, many software patent owners could be holding potentially
worthless, invalid patents (patent-ineligible).48 Since Alice, over a dozen
patent cases involving computer-implemented business methods have been
considered by the Federal Circuit, and all but one have been invalidated based
on Alice.49
While the current trend of patent court decisions appears to limit the
scope of patent-eligible subject matter, it has not always been the case.
Business methods, the patent-eligibility of which was called into question
by Bilski and Alice, were not permitted under a theory of being patentineligible subject matter. But in 1998, the Federal Circuit in State Street
Bank & Trust Co. v. Signature Financial Group, held business methods as
being patent-eligible subject matter.50 Remember the “pendulum”? But
now, after the Bilski and Alice decisions, the many business method patents
44. Bilski v. Kappos, 561 U.S. 593, 608-09 (2010).
45. Mayo Collaborative Servs. v. Prometheus Labs. Inc., 132 S.Ct. 1289, 1294 (2012).
46. Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107, 2111
(2013)
47. Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347, 2352 (2014).
48. Software patent claims frequently were written using general and vague language in
order to obtain a broad claim scope, making the invention appear even more abstract than it is.
49. DDR Holdings v. Hotels.com, 773 F.3d 1245 (Fed. Cir. 2014). This number is even
higher if you take into account the number of AIA post grant CBMs that have been invalidated by
the USPTO.
50. State Street Bank & Trust Co. v. Signature Fin. Grp., 149 F.3d 1368, 1370 (Fed. Cir.
1998).
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that issued under the blessing of State Street are again suspect, and many
likely are invalid as being patent ineligible. Here today, gone tomorrow,
depending on the changing government policies and goals swayed by
public opinion. Inventions that only several years ago were considered
patent-eligible are today patent-ineligible.
These changes have very practical considerations for company A and
company B. For example, company A’s could have an invention involving an
isolated gene or a diagnostic test embracing a natural law or phenomenon, and
company B’s invention could involve computer software that utilizes facial
recognition technology. Both companies could each have an inventive business
method of marketing their inventions. Given the current state of law in these
technological areas, and the new AIA provisions, however, companies A and B
may wish to consider foregoing patent protection at least until the law is more
settled, and instead consider the merits of pursuing trade secret protection.
Clearly, trade secret protection is more desirable for inventions that are
potentially patent ineligible. Any information can be protected as a trade secret.
An abstract idea, for example, was recently confirmed by the California Court of
Appeals to be protectable trade secret subject matter.51
Obviousness
An invention must be deemed nonobvious to be granted patent protection,
and patent examiners routinely reject patent applications based on grounds that
the inventions claimed are obvious. In 2006, in KSR International Co. v.
Teleflex Inc. (“KSR”) the Supreme Court gave patent examiners and the courts
more weapons to shoot down inventions as obvious to one of ordinary skill in
the art.52 Prior to KSR, an invention was rejected by a patent examiner as being
obvious only if the examiner found a reference or combination or references
containing a teaching, suggestion, or motivation that would lead one of ordinary
skill in the art to arrive at the invention. Post-KSR, an invention could be
rejected as being obvious if, among other things, the patent examiner considered
the invention predictable, within the routine design skill of one of ordinary skill,
or “obvious to try,” even in the absence of any explicit teaching, suggestion, or
motivation. Consequently, more and more inventions now fail to qualify for
patent protection because they are deemed obvious under the new standards
created by KSR and its progeny.
Although an inventor by law can appeal the examiner’s obviousness
rejection to the Patent Trial and Appeals Board (“PTAB”) or even to the CAFC,
the appeal process is lengthy, costly, and does not guarantee a win for the
inventor. In fact, anecdotally and based on some very reliable data, the odds

51. Altavion, Inc. v. Konica Minolta Sys. Lab. Inc., 2014 WL 1846104 (Cal. Ct. App. May
8, 2014).
52. KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007).
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may be against the patent owners.53 The post grant proceedings enacted under
the AIA have been an effective killing ground for granted patents. It may even
be the case going forward that most patents will be granted only for the truly
inventive and game-changing ideas.
Even though some of the best and, ultimately, most patent worthy ideas are
simple solutions that seem obvious in hindsight, companies A and B may wish
to avoid the sometimes lengthy and almost always very expensive road to
proving that their simple inventions are nonobvious. Thus, companies A and B
may wish to consider, under certain circumstances, protecting their inventions as
trade secrets, even if they ultimately could be patented.54 The money spent on
patent procurement, enforcement, and patent challenges would be better spent on
research and development of future generations of inventions. At the same
time, they could be kept as a trade secret for very little relative money.55
2.

Terms of Protection

Patent terms are expressed as twenty years from the application filing date
or earliest priority date. Realistically, because patents are not granted the day
they are filed, the period of time a granted patent may be enforced is less than
this 20 year term, and in some cases substantially less.56 The ideal term of
protection needed for any given invention may depend primarily on the
technology in question. For example, for company B, an innovative and
patentable electronic component used in a smartphone device may have a
lifespan of as little as one to three years because it becomes obsolete and is
replaced by next generation of technology. In these cases, the technology’s
lifespan is far less than the term of most issued patents. In contrast, for company
A, many patented and approved life science inventions do not reach the market
until well into the patent term and often risk challenges after FDA approval. 57

53. USPTO, Inter Partes Review Petitions Terminated to Date (Oct. 16, 2014), available at
http://www.uspto.gov/ip/boards/bpai/stats/inter_partes_review_petitions_terminated_updated_20
141016-.pdf.pdf.
54. However, readers should not lose sight of the fact that some patentable inventions may
not be worth protecting as a trade secret. The information/invention must be capable of being
kept a secret, and not susceptible to reverse engineering. Some technologies by their nature, such
as secret processes, e.g., Coca Cola®, may not be susceptible to being reversed engineered, but
no matter how difficult it may be to reverse-engineer a technology if there is enough money
involved assume that it will be. Some technologies are obsolete in the span of 1year-5 years, and
utility patent protection in those circumstances may be a reckless endeavor, while trade secret
protection has great value.
55. See supra note 48.
56. Patents are only enforceable once granted, so the patent terms may vary depending on the
amount of time an application is pending in the USPTO. Although beyond the scope of this article,
patent terms vary widely based on technologies, USPTO backlogs, and a myriad other factors. The
terms of most granted patents are likely of sufficient duration to at least recoup the invested costs of
creating the technology and securing the patent(s) if they are commercialized and/or otherwise
monetized.
57. For purposes of illustration, these are oversimplifications, but nonetheless useful to
illustrate two opposite ends of the spectrum.
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In the case of a blockbuster drug, company A can protect portions of its
drug and know-how regarding any improved manufacturing processes as trade
secrets without violating any regulations, and thus could substantially benefit
from its innovations long after the expiration of its patent(s). Of course, as
already noted, the information can be protected as a trade secret only so long as it
is kept secret, until the information is reverse engineered, or otherwise
independently developed by others. In the case of company B’s smartphone
component, the patent term should be more than adequate to protect the use of
that component before it is replaced by newer technology.58 Large companies
with financial resources are able to extend patent protection for their key
technologies by continuously innovating in that space and then seeking followon patents. Smaller companies, like company B, may not have access to the
same financial resources to pursue this strategy.
Trade secrets, on the other hand, offer a more flexible approach to
information (technology) protection, and do not require the cooperation of a
sometimes stubborn governmental agency such as the USPTO. For example,
the scope of the trade secret being protected can evolve together with the
information or product as it undergoes changes and improvements. Thus, a trade
secret is more effective at protecting the subsequent improvements and evolution
of an invention without incurring significant additional costs and/or efforts.
3.

Enforcement

To enforce a patent, a company must prove infringement. But depending
on the technology and type of protection obtained, infringement may be
difficult to prove. For example, processes and methods of manufacturing a
drug can be difficult or sometimes impossible to detect without the discovery
afforded by an expensive litigation. Thus, if company A held a patent on the
process or method of manufacturing a drug, it may have to search for potential
infringers with little or no hard evidence of infringement, other than
circumstantial evidence of the existence of the same drug being manufactured,
before the filing of a complaint. Successful outcomes in these types of
situations are less predictable owing to heightened pleading requirements to
support a cause of action for patent infringement.59 Thus, some companies in
these circumstances may intentionally pursue trade secret protection for
processes and methods of manufacturing a product if infringement is difficult
to detect.60

58. Of course the challenge here may be that the technology becomes obsolete before a patent is
ever issued. This factor alone strongly suggests consideration of trade secret protection if it is available.
59. See Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 545 (2007).
60. Of course the risk in these situations is that an issued patent to another party may prevent the
trade secret owner from making or using her technology absent a valid defense such as prior user rights.
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To show literal infringement of a patent, the accused product must
embody each and every limitation of a single claim. If the accused product
does not meet a single limitation of a claim, however minor, the accused
product does not literally infringe.61
Proof of trade secret misappropriation, in contrast, can be based on
circumstantial evidence.62 The accused product or method need not be
identical to the stolen information—a showing of unauthorized access and
substantial similarity is sufficient. And unlike patent cases where a defendant
can design around the patent to avoid infringement, a trade secret defendant’s
design around attempts will not suffice, because designing around a trade
secret cannot undo the knowledge and unauthorized use of the trade secret to
facilitate the design around.
Patent enforcement may also be difficult where the theft (infringement)
occurs abroad, by foreign individuals or entities in jurisdictions that do not
enforce patents. This is becoming an increasing threat for many companies
due to the rapid internationalization of businesses and their practices. U.S.
patents cannot be enforced abroad, and even if the company has applied for
and obtained patents in a foreign jurisdiction, enforcement of those patents can
be challenging owing to different legal systems, procedures, and social norms
and bias.
Similarly, trade secret enforcement proceedings on foreign soil are
subject to the same barriers as patent enforcement noted above. Finally,
despite improved protections under new laws and business and political
doctrines of international reciprocity for IP throughout the developed and
developing world, businesses engaged with partners (JV or otherwise) in
developing countries, such as China for example, still believe that their
technology, trade secrets, and/or other confidential information shared with
their developing country counterparts under confidentiality and non-isclosure
agreements will be taken without any legal consequence or recourse.
Anecdotally, this is just part of the risk-reward business analysis a company
considers before proceeding.
4.

Injunctions

If either company A or company B generally considers money damages as
inadequate, trade secret protection may be the better option. In 2006, the
Supreme Court raised the threshold for obtaining injunction for patent
infringement.63 What was once an automatic injunction upon a finding of patent
infringement, became instead discretionary relief that is granted only upon the
61. Although equivalents may be relied on to show patent infringement, in practice plaintiffs
rarely win on equivalents because that doctrine is substantially encumbered by a number of limitations.
See generally Lee Petherbridge, On the Decline of the Doctrine of Equivalents, 31 CARDOZO L. REV.
1371, 1375 (2010).
62. Greenberg v. Croydon Plastics Co., 378 F. Supp. 806, 814 (E.D. Pa. 1974).
63. eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006).
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showing of four factors: (1) whether the plaintiff suffered an irreparable injury;
(2) whether remedies available at law are inadequate to compensate for that
injury; (3) whether considering the balance of hardships between the plaintiff
and defendant, a remedy in equity is warranted; and (4) whether the public
interest would not be disserved by a permanent injunction.64 The results were
almost immediate, with substantially fewer injunctions.65 By reducing the
threat of an injunction, the Court in the eyes of some decreased the
potential reward for asserting patent infringement and the risk in defending
against patent infringement charges.66
By contrast, an injunction remains the primary form of relief in trade
secret cases because the law recognizes that once a trade secret is revealed
it can never be recovered. The standard for granting an injunction in trade
secret cases is therefore considered low.67 Finally, injunctions in trade
secret cases are not limited to actual misappropriations but also threatened
misappropriations.68
5.

Prior User Rights

Pre-AIA, a prior user who kept his invention a trade secret was
potentially liable for infringement of a patent for the same invention that
was later independently developed and patented by another party.69 PostAIA, there is a “prior user right” defense that allows a prior user to
continue using the invention without risking infringement of a later
obtained patent.70 The defense is now available to all prior users to defend
against later patents covering their inventions.71
However, the prior user defense is not without significant limitations.
For example, the prior user must establish that they used the invention
commercially in the U.S., more than one year before the filing date of the
patent application or the public disclosure date of the patented invention.72
Moreover, the defense cannot be licensed, assigned, or transferred, other
64. Id.
65. See, e.g., Ernest Grumbles, III et al., The Three Year Anniversary of eBay v.
MercExchange: A Statistical Analysis of Permanent Injunctions, INTELLECTUAL PROPERTY
TODAY (2009).
66. This notion that injunctions are the exception not the rule is premised on the belief that
the relative positions of the parties in dispute can be resolved by money damages.
67. See, e.g., Pamela Samuelson, Principles for Resolving Conflicts Between Trade Secrets
and the First Amendment, UC Berkeley Public Law Research Paper No. 925056, available at
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=925056.
68. See Pepsico v. Redmond, 54 F.3d 1262, 1267 (7th Cir. 1995)
69. A limited prior user defense was only available for business method patents pre-AIA.
See § 5(a), 125 Stat. at 297. See App. B (section 273 under the AIA is reproduced for reference).
70. See, e.g., 35 U.S.C. 273 (2011).
71. Id.
72. Id. at (a)(2).
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than in connection with an assignment or transfer of the entire business.
Additionally, the defense is only applicable to the regional site where the
invention was initially used. A prior inventor who used a secret
manufacturing process in California, for example, which is later patented
by another party, cannot later add a plant in Virginia without being
potentially liable for infringement committed at that plant. Also, the AIA
provides an explicit exception to the defense for patents owned by or
assigned to universities and their affiliates. For example, if a prior user
commercially utilized a secret synthetizing method, and a university later
patented the same method, the prior user is liable for infringement of the
later patent. The university exception was created to help universities that
“depend on publication and disclosure to further research and
innovation.”73
Despite these limitations, prior user rights give companies A and B a
powerful defense against what in the old days (pre-AIA) used to be a major
shortcoming to using trade secrets instead of seeking patent protection. It
could even be argued from this change enacted by the AIA that the
government acknowledged and even sanctioned the choice of protecting
patentable subject matter as a trade secret, something that would have
surprised the Kewanee Court.
6.

Disclosure

Trade secrets and the laws protecting them are premised on the nondisclosure of economically valuable information. If a trade secret is embodied
in a product that the public can reverse engineer, or is at risk of accidental
disclosure, then trade secret protection is not a good candidate for protecting
the information. In these circumstances patent protection may be the only
recourse for patentable subject matter. However, the public disclosure
required under the patent laws for compliance with the written description
requirement could also discourage some companies from pursuing patent
protection. For example, companies A and B may prefer to protect their
patentable inventions as trade secrets to prevent the flow of information to their
competitors. In contrast to trade secrets, the disclosures in patent applications,
once published, can give the competition important strategic insights into what
a company is doing or may be pursuing. Such competitive intelligence might
give bigger and better financed rivals a competitive head start in developing a
competing product.74 Moreover, rivals may use this information to design
around or even make patentable improvements to the company’s inventions.
Although the U.S. patent system was created for just this purpose—to share
knowledge and spur innovation—some companies may elect to stay
competitive by not publically sharing their knowledge base, and are willing to
take the risk of letting a third party file first under the AIA.

73. 157 Cong. Rec. S5402, S5427 (statement of Sen. Kohl).
74. Ignatius Horstmann, et al., Patents as Information Transfer Mechanisms: To Patent or
(Maybe) Not to Patent, 93(5) J. OF POL. ECON. 837 (1985).
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Costs

At the end of the day, regardless of what a company believes is the best
and most effective protection for its information (innovations, invention(s)), it
will likely choose the option(s) that it can afford. It is generally true that
procuring patents is, relatively speaking, far more expensive than creating a
trade secret.75 Patent prosecution fees and costs, depending on the length of
prosecution and the countries in which protection is sought, can escalate
quickly and wander into the $100,000-$200,000 plus range for a global
strategy. In addition to the basic legal fees and filing costs, preliminary prior
art searches and translation costs all add to the bottom line.76 77
All U.S. patents, foreign applications, and foreign patents require the
payment of maintenance fees (annuities) that must be paid to keep the
applications/patents from becoming abandoned and/or expiring before their
legal expiration date. Companies are responsible for policing their own
patents and must have sufficient funds to enforce and/or defend the patent.
Practically speaking, the amount of protection, or benefit, that a company
gains from a patent depends on how well the company is policing third
party infringement activities, and proving liability in court. These
enforcement efforts all require considerable resources and time.78
In contrast, maintaining a trade secret does not require filing anything in a
patent office and, generally speaking, has no large upfront administrative
costs.79 Trade secrets historically were recommended as the low-budget

75. In this sense, we are only looking at the cost of creating the protection, e.g., the cost of
drafting and filing a patent application, and then prosecuting the patent application to allowance.
For patent protection, these relative costs are typically much higher. The other costs include
maintenance, enforcement and defense. For a large company with many employees and trade
secrets, these “other” relative costs can substantial.
76. The AIA significantly expanded the pool of available prior art for an invention by,
among other things, removing geographic and language restrictions on some prior art. See,
MaCharri Vorndran-Jones, et al., Top Five Dangers for the AIA Unwary, Landslide May/June
2013, at 10, 10.
77. It is a common practice, but one that is not legally required, to retain a private search
firm and conduct your own prior art search prior to filing your patent application, to help identify
the most relevant prior art and thereby eliminate any expensive surprises that could undermine
your application. Therefore, it would be fair to say that one goal of any patent owner is to know
about the existence of prior art before his competitor does so that these potentially damaging
“prior art” surprises can be minimized and the costs contained.
78. In the United States at least, one of the biggest complaints about litigation, other than its
relative high costs, is the time consumption and inconveniences imposed on the litigating parties,
including document discovery, depositions, and the trial.
79. See note 80. To the extent that one asks about the cost of innovation or creating the
innovation (e.g., R&D costs), those costs are the same, regardless of whether you choose to
protect it as a trade secret or in a patent.
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alternative to protect inventions.80 However, depending on the nature of the
protected information and the size of the operation involving the protected
information, maintaining secrecy can require significant resources. For
example, because jurisdictions differ as to the “reasonable” security measures
required for a company to qualify for trade secret protection, a large multinational company with multiple branches may have to have a very large
security infrastructure to qualify as “reasonable” security measures.
Depending on the nature of the information sought to be protected, this could
require information security measures and networks, access restrictions, and
bulletproof employee confidentiality agreements. Where the trade secret
involves secret manufacturing techniques or processes, a company may need to
restrict access to the building and/or modify its facilities to make them more
secure against potential theft or inadvertent disclosure to the public or nonessential employees.
The costs of maintaining a trade secret in the information age are even
higher. In Sasqua Group, Inc. v. Courtney, for example, a court held that the
taking of confidential information from Sasqua Group did not amount to
misappropriation of a trade secret, even though the information “may well have
been a protectable trade secret in the early years of Sasqua’s existence when
greater time, energy and resources may have been necessary to acquire the level
of detailed information to build and retain the business relationships at issue
here,” but that “for good or bad, the exponential proliferation of information
made available through full-blown use of the Internet and the powerful tools it
provides to access such information in 2010 is a very different story.”81 Thus,
depending on the facts of a particular case, here the Sasqua Group information,
companies in the information age may need to expend significant resources in
sophisticated encryption, tracking, monitoring, and log-in procedures to satisfy
the security measures needed for courts to consider that it has taken “reasonable”
security measures to guard its trade secrets.
B. Choosing Both Patents and Trade Secrets
The analysis does not stop here. An often neglected and crucial piece of
analysis is whether or not a company can use both patents and trade secrets to
protect different aspects of its invention. The undisputable answer is yes! Patents
and trade secrets are not incompatible but complementary, and obtaining the
benefit of both can be accomplished in several ways.

80. While it may be true that there are no significant upfront maintenance costs, the costs of
developing the trade secret, whether a secret process or other patentable invention, or even a nonpatentable customer list developed over many, many years of blood, sweat and tears, can be
substantial.
81. Sasqua Grp., Inc. v. Courtney, No. 10-582, 2010 U.S. Dist. WL 3613855, at *22
(E.D.N.Y. Aug. 2, 2010) report and recommendation adopted, 2010 WL 3702468 (E.D.N.Y.
Sept. 7, 2010).
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Pre-publication

While the publication (disclosure) of a patent application is at odds with
the concept of trade secret protection, the mere submission of a patent
application does not destroy any trade secret disclosed therein. After its initial
filing, the first eighteen months of the life of a U.S. patent application is
maintained in secrecy. During this period, as long as the trade secret described
in the patent application continues to be regarded as such, and reasonable
confidentiality measures are followed, the information does not lose its
secrecy, and wrongful use or disclosure of the information is actionable.82 The
outcome in a suit for such wrongful use or disclosure of that trade secret is
independent of whether the patent application eventually issues as a patent, or
if the patent is subsequently invalidated or is held unenforceable.83
At the end of the eighteen-month period, a company may choose to
avoid publication (and disclosure of the trade secret) by expressly
abandoning the patent application. The company can also protect the
information as a trade secret beyond the patent application’s first eighteen
months by filing a request for nonpublication with the patent application,
but only in limited circumstances.84 If the request is properly filed, then the
application is published only after the application is allowed to mature into
a patent. The nonpublication option is available for almost all inventions,
and is only rescinded if the company seeks patent protection in a foreign
country with a request for publication. This extra period of nondisclosure
could be measured in years and is likely invaluable to a small start-up
company; the early years in the research and development of a product is
crucial, and the nondisclosure of the company’s patent application in those
years could give the company enough lead time to buffer the eventual
publication and disclosure of its invention. Maintaining an application in
secrecy until issuance also gives the inventor more time to evaluate the
scope of protection that it will receive from the patent application. If the
company is satisfied with the scope, it could choose to abandon its trade
secret protection. If not satisfied, it could choose to maintain the invention
as a trade secret, and continue to prosecute the patent application by filing
continuation applications until it gets the scope of patent protection needed.
Ultimately, of course, the company could just elect to abandon the
application and maintain the information as a trade secret.

82. See Big Vision Private, Ltd. v. E.I. DuPont De Nemours & Co., No. 11-8511, 2014 U.S.
Dist. LEXIS 26991, at **121-29 (S.D.N.Y. Feb. 10, 2014).
83. While the “outcome” may be independent one can imagine all kinds of hypothetical
scenarios where the alleged harm ranges from severe to insignificant.
84. 35 U.S.C. § 122 (2012).
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Different Aspects of the Invention

Even after a patent application is published or a patent issues and is
published, patent protection and trade secret protection are not mutually
exclusive. Each patent is limited to one invention, and in practice, each
patent may only cover a limited aspect of each invention. Thus, a patent
needs only to provide a written description and an enabling disclosure for
the invention claimed, and not all information needed to explain how to
make and use the entire broad invention.85 In this context, both patents and
trade secrets can be pursued.
Accordingly, a more important inquiry for a company should be
deciding which aspects of an invention to patent and which aspects to
protect as trade secrets. Both forms of protection should be considered for
protecting valuable innovation. As demonstrated, patents and trade secrets
offer different types and levels of protections, and a company can use both
to maximize the benefits afforded by these protections. One scholar
observed that a combination of different intellectual property species can
be used to: 1) cover additional subject matter, 2) strengthen exclusivity, 3)
invoke additional remedies in litigation, and 4) stand up if a primary
intellectual property right becomes invalid.86
For example, a drug sold by company A, the process of manufacturing
the drug, the drug’s ingredients (the raw materials), and even the third party
suppliers of the ingredients, all ultimately contribute to the success of
company’s drug. So for example, if a patent is obtained on the drug, it is
possible that the manufacturing process (or improvements thereof) and the
supplier list can both be protected as trade secrets. The raw materials also may
be protectable as a trade secret. This strategy not only offers two layers of
protections and remedies, it may give company A a competitive edge after the
patent on the drug expires. Wyeth, for example, took advantage of this type of
layered protection by obtaining an exclusive market on its blockbuster drug
during the pendency of its patent on the drug, and retaining its competitive
advantage after expiration of the patent by keeping the drug’s manufacturing
method a trade secret.87 When its competitor acquired the manufacturing
method from Wyeth illegally, Wyeth was able to successfully bring suit
against its competitor for trade secret misappropriation even though the patent
on the drug itself had expired.88
85. While somewhat of an oversimplification because of the very different nature of some
inventions, for example, pharmaceuticals on one end of the spectrum and electronics/computers
on the other end, it nonetheless is true. Additionally, innovations or improvements following the
filing of a patent application do not need to be disclosed and may be maintained as trade secrets.
86. Karl F. Jorda, Patent and Trade Secret Complementariness: An Unsuspected Synergy,
48 WASHBURN L.J. 1, 13 (2008).
87. Wyeth v. Natural Biologics, Inc., No. 98-2469, 2003 U.S. Dist. WL 22282371, at *19
(D. Minn. Oct. 2, 2003).
88. Id. at *26-*29.
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Best Mode

Company B could use patents and trade secrets to cover the same aspect
of the same invention at the same time. This could be achieved, under certain
circumstances, by protecting the best mode of carrying out a patented
invention as a trade secret.
The patent statute requires that the patent disclosure “set forth the best
mode contemplated by the inventor or joint inventor of carrying out the
invention.”89 Because of this requirement, many believe that the best mode of
carrying out an invention cannot be kept as a trade secret if the invention is
described in a patent. This is not always true. First, the “best mode”
requirement applies only to the best mode “contemplated by the inventor or
joint inventor.”90 Thus, if company B, as the assignee of a patent, knows a
better mode unknown to the inventor or joint inventor, company B is under no
obligation to reveal it.91
Also, the best mode requirement applies to only the best mode
contemplated at the time of filing the patent application. Thus, if the best
mode (or, more aptly here, a better mode) of the invention was discovered after
the application was filed, as is frequently the case, then it may be kept as a
trade secret.92 In practice, the “better” mode of an invention often arises after
the initial patent application is filed because applications are usually filed in the
earlier stages of the research and development, and better modes of carrying
out the invention are discovered or perfected afterwards.
Pre-AIA, failure to disclose the best mode was grounds to find a patent
invalid or unenforceable. Curiously, although the AIA retained the
requirement to disclose the best mode to the USPTO, it expressly eliminated
the consequences of failing to do so. Thus, while a patent applicant must still
disclose the best mode to obtain a patent, failure to do so will not render the
patent obtained invalid or unenforceable.93

89. 35 U.S.C. § 112 (2011).
90. Id.
91. See Glaxo, Inc. v. Novopharm Ltd., 830 F. Supp. 871, 881 n9, (E.D.N.C. 1993).
92. MGP Ingredients, Inc. v. Mars, Inc., 465 F. Supp. 2d 1109, 1115-16 (D. Kan. 2006).
93. Because the USPTO has no procedural mechanisms for investigating whether or not the
best mode was disclosed in a patent application, the best mode requirement at this point appears
to be at best a formality. It remains to be seen what impact, if any, the failure to disclose the best
mode may have during litigation, as there is no developed case law on point. For example, does
the mere formality of requiring the best mode to be disclosed during prosecution mandate legal
consequences during litigation for the failure to comply with that formality? And, if so, what are
those consequences?
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Conclusion

The intersection of patents and trade secrets can be described as a
delicate balance of disclosure and secrecy. The USPTO views trade secret
protection as “an alternative to patent protection.”94 But these authors
believe that trade secret protection is better viewed as a complement to
patent protection not as an alternative. Therefore, the proper inquiry for
any company is not patent or trade secret, but rather how can we use both
patents and trade secrets together? Understanding and using both forms of
protection can provide a company the best of both worlds, and give it a
competitive advantage.

94. Office of Policy and External Affairs: Patent Trade Secrets, USPTO, http://www.uspto
.gov/ip/ global/patents/ir_pat_tradesecret.jsp (last visited Mar. 23, 2015).

